Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo
Status:
Unknown status
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare efficacy and safety of two formulations of
teriparatide 20 mcg/day plus calcium and vitamin D in postmenopausal women with osteoporosis.